In a challenging year for Adagio Therapeutics (NASDAQ:IVVD), the biotech company's stock has tumbled to a 52-week low, reaching a price level of just $0.38. This latest dip underscores a prolonged ...
Inc. has been notified by the Nasdaq Stock Market of a potential delisting due to its Market Value of Listed Securities falling below the required minimum. The laboratory analytical instruments ...
As the first earnings cycle of 2025 is ramping up, so are the announcements of new share buyback authorizations. Among these announcements, three big-name U.S. stocks stick out so far, all of which ...
China Liberal Education Holdings Limited (CLEU) stock has reached a new 52-week low, trading at $1.03. While the company maintains a strong liquidity position with a current ratio of 16.25 and more ...
Blackwell production has ramped up to 100%; there are plans for capacity expansion, including into the U.S., and the next-gen technology will soon be available. Rubin, the next iteration of NVIDIA’s ...
Results that may be inaccessible to you are currently showing.